We are live on
!
Find out more
RA
Royce & Associates Portfolio holdings
AUM
$12.4B
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+28.76%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$12.4B
AUM Growth
+$2.29B
(+23%)
Cap. Flow
-$8.07M
Cap. Flow
% of AUM
-0.07%
Top 10 Holdings %
Top 10 Hldgs %
9.07%
Holding
848
New
74
Increased
361
Reduced
233
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$43.3M |
| 2 |
Mine Safety
MSA
|
+$37.1M |
| 3 |
YSWY
Yesway Inc
YSWY
|
+$34.7M |
| 4 |
Dorman Products
DORM
|
+$24.6M |
| 5 |
Avantor
AVTR
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cohu
COHU
|
+$54.5M |
| 2 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$51.1M |
| 3 |
MKS Inc
MKSI
|
+$44.5M |
| 4 |
Vishay Intertechnology
VSH
|
+$40.2M |
| 5 |
Littelfuse
LFUS
|
+$35.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 27.04% |
| 2 | Technology | 19.45% |
| 3 | Financials | 14.84% |
| 4 | Consumer Discretionary | 12.86% |
| 5 | Healthcare | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
BellRing Brands
BRBR
$1.24B
| $166K | ﹤0.01% |
+12,822
| New | +$155K |
|
|
CCRN
727
DELISTED
Cross Country Healthcare
CCRN
| $143K | ﹤0.01% |
10,790
-534,590
| -98% | -$6.33M |
|
728
Angi Inc
ANGI
$197M
| $136K | ﹤0.01% |
22,867
+11,754
| +106% | +$72.5K |
|
729
AMC Global Media
AMCX
$520M
| $124K | ﹤0.01% |
12,444
| – | – |
|
730
Taboola.com
TBLA
$1.03B
| $123K | ﹤0.01% |
24,575
| – | – |
|
731
GoodRx Holdings
GDRX
$1.22B
| $110K | ﹤0.01% |
38,114
| – | – |
|
732
Teladoc Health
TDOC
$1.19B
| $109K | ﹤0.01% |
+12,912
| New | +$85.9K |
|
733
Cricut
CRCT
$1.19B
| $106K | ﹤0.01% |
24,100
-355
| -1% | -$1.52K |
|
734
Bumble
BMBL
$360M
| $105K | ﹤0.01% |
32,767
| – | – |
|
735
Repay Holdings
RPAY
$307M
| $99.1K | ﹤0.01% |
23,587
| – | – |
|
736
Coursera
COUR
$1.73B
| $97.5K | ﹤0.01% |
+17,289
| New | +$98.2K |
|
737
BRC Group Holdings
RILY
$285M
| $93.4K | ﹤0.01% |
11,622
| – | – |
|
738
Acco Brands
ACCO
$396M
| $89.5K | ﹤0.01% |
21,518
| – | – |
|
739
Real REMAX Group Inc. Common Stock
REAX
$506M
| $82.3K | ﹤0.01% |
+4,520
| New | +$91.8K |
|
740
Ironwood Pharmaceuticals
IRWD
$676M
| $78.1K | ﹤0.01% |
+18,553
| New | +$71.5K |
|
741
Acacia Research
ACTG
$437M
| $68.1K | ﹤0.01% |
14,611
| – | – |
|
742
Myriad Genetics
MYGN
$295M
| $67.1K | ﹤0.01% |
+11,748
| New | +$53.3K |
|
743
Resources Connection
RGP
$146M
| $61.8K | ﹤0.01% |
14,550
| – | – |
|
744
Marqeta
MQ
$1.71B
| $61K | ﹤0.01% |
3,756
| – | – |
|
745
MiMedx Group
MDXG
$660M
| $56.7K | ﹤0.01% |
14,720
| – | – |
|
|
CMRC
746
Commerce.com Inc Series 1
CMRC
$209M
| $55.9K | ﹤0.01% |
+18,891
| New | +$54.1K |
|
|
NAGE
747
Niagen Bioscience
NAGE
$256M
| $38.8K | ﹤0.01% |
+12,169
| New | +$49.4K |
|
748
ADMA Biologics
ADMA
$2.11B
| – | – |
-27,124
| Closed | -$244K |
|
749
Adient
ADNT
$1.44B
| – | – |
-30,099
| Closed | -$608K |
|
750
Addus HomeCare
ADUS
$2.17B
| – | – |
-6,048
| Closed | -$566K |
|
Similar funds
JF
WRCM
LC
AIM
SC
ERSOT
BAMF
Royce & Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Royce & Associates held 848 positions worth $12.4B, up 23% from $10.1B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Royce & Associates's Q2 2026 filing shows 74 new, 361 increased, 233 reduced and 101 closed positions. Its largest new stake was Manhattan Associates: 314,304 shares worth $43.8M. The largest sale was Cohu, an estimated $54.5M.
By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- Royce & Associates's largest Q2 2026 buy was Manhattan Associates: 314,304 shares worth $43.8M.
- Royce & Associates added most to Mine Safety in Q2 2026, an estimated $37.1M increase.
- Royce & Associates's biggest Q2 2026 reduction was Cohu, cutting an estimated $54.5M.
- Royce & Associates fully exited Transmedics in Q2 2026, selling an estimated $24.3M.
- Royce & Associates's ten largest holdings make up 9.1% of its $12.4B portfolio in Q2 2026.
- Royce & Associates opened 74 new positions and closed 101 in Q2 2026.
- Royce & Associates's portfolio value rose 23% quarter-over-quarter to $12.4B.
Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.